{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:11:26Z","timestamp":1773288686627,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,3,13]],"date-time":"2010-03-13T00:00:00Z","timestamp":1268438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00262-010-0840-2","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T17:19:05Z","timestamp":1268414345000},"page":"1121-1130","source":"Crossref","is-referenced-by-count":8,"title":["Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow\u2013bone marrow transplantation plus fetal thymus transplantation"],"prefix":"10.1007","volume":"59","author":[{"given":"Naoki","family":"Hosaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneo","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ikehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,13]]},"reference":[{"key":"840_CR1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02469832","volume":"12","author":"T Toge","year":"1982","unstructured":"Toge T, Oride M, Yanagawa E et al (1982) Prognostic significance of lymphocyte proliferative responses to mitogens in gastric cancer patients. Jpn J Surg 12:424\u2013428","journal-title":"Jpn J Surg"},{"key":"840_CR2","first-page":"374","volume":"14","author":"SN Das","year":"1985","unstructured":"Das SN, Khanna NN, Khanna S (1985) A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis. Ann Acad Med Singapore 14:374\u2013381","journal-title":"Ann Acad Med Singapore"},{"key":"840_CR3","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/1097-0142(19800415)45:8<2074::AID-CNCR2820450814>3.0.CO;2-K","volume":"45","author":"A Adler","year":"1980","unstructured":"Adler A, Stein JA, Ben-Efraim S, Immunocompetence, immunosuppression, human breast cancer. III (1980) Prognostic significance of initial level of immunocompetence in early and advanced disease. Cancer 45:2074\u20132083","journal-title":"Cancer"},{"key":"840_CR4","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.4049\/jimmunol.164.11.5635","volume":"164","author":"B Adkins","year":"2000","unstructured":"Adkins B, Charyulu V, Sun QL, Lobo D, Lopez DM (2000) Early block in maturation is associated with thymic involution in mammary tumor-bearing mice. J Immunol 164:5635\u20135640","journal-title":"J Immunol"},{"key":"840_CR5","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.lfs.2005.05.038","volume":"77","author":"D Mandal","year":"2005","unstructured":"Mandal D, Bhattacharyya A, Lahiry L, Choudhuri T, Sa G, Das T (2005) Failure in peripheral immuno-surveillance due to thymic atrophy: importance of thymocyte maturation and apoptosis in adult tumor-bearer. Life Sci 77:2703\u20132716","journal-title":"Life Sci"},{"key":"840_CR6","first-page":"89","volume":"23","author":"R Carrio","year":"2009","unstructured":"Carrio R, Lopez DM (2009) Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1. Int J Mol Med 23:89\u201398","journal-title":"Int J Mol Med"},{"key":"840_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.intimp.2005.09.005","volume":"6","author":"D Mandal","year":"2006","unstructured":"Mandal D, Lahiry L, Bhattacharyya A, Bhattacharyya S, Sa G, Das T (2006) Tumor-induced thymic involution via inhibition of IL-7R alpha and its JAK-STAT signaling pathway: protection by black tea. Int Immunopharmacol 6:433\u2013444","journal-title":"Int Immunopharmacol"},{"key":"840_CR8","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V96.12.3838","volume":"96","author":"V Bronte","year":"2000","unstructured":"Bronte V, Apolloni E, Cabrelle A et al (2000) Identification of a CD11b(+)\/Gr-1(+)\/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96:3838\u20133846","journal-title":"Blood"},{"key":"840_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4049\/jimmunol.165.2.779","volume":"165","author":"SA Kusmartsev","year":"2000","unstructured":"Kusmartsev SA, Li Y, Chen SH (2000) Gr-1\u00a0+\u00a0myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3\/CD28 costimulation. J Immunol 165:779\u2013785","journal-title":"J Immunol"},{"key":"840_CR10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20022227","volume":"98","author":"M Terabe","year":"2003","unstructured":"Terabe M, Matsui S, Park JM et al (2003) Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 98:1741\u20131752","journal-title":"J Exp Med"},{"key":"840_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Ono M, Setoguchi R et al (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212:8\u201327","journal-title":"Immunol Rev"},{"key":"840_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2005.09.006","volume":"43","author":"P Hoffmann","year":"2006","unstructured":"Hoffmann P, Edinger M (2006) CD4+CD25+ regulatory T cells and graft-versus-host disease. Semin Hematol 43:62\u201369","journal-title":"Semin Hematol"},{"key":"840_CR13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00262-005-0092-8","volume":"55","author":"K Kono","year":"2006","unstructured":"Kono K, Kawaida H, Takahashi A et al (2006) CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 55:1064\u20131071","journal-title":"Cancer Immunol Immunother"},{"key":"840_CR14","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1158\/1078-0432.CCR-05-1244","volume":"11","author":"D Wolf","year":"2005","unstructured":"Wolf D, Wolf AM, Rumpold H et al (2005) The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11:8326\u20138331","journal-title":"Clin Cancer Res"},{"key":"840_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/08880010490477284","volume":"21","author":"A Verdeguer","year":"2004","unstructured":"Verdeguer A, Mu\u00f1oz A, Ca\u00f1ete A et al (2004) Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon). Pediatr Hematol Oncol 21:495\u2013504","journal-title":"Pediatr Hematol Oncol"},{"key":"840_CR16","first-page":"401","volume":"244","author":"A Fefer","year":"1987","unstructured":"Fefer A, Sullivan KM, Weiden P et al (1987) Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 244:401\u2013408","journal-title":"Prog Clin Biol Res"},{"key":"840_CR17","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.174.5.3051","volume":"174","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG (2005) Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 174:3051\u20133058","journal-title":"J Immunol"},{"key":"840_CR18","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood.V97.10.3292","volume":"97","author":"T Kushida","year":"2001","unstructured":"Kushida T, Inaba M, Hisha H et al (2001) Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL\/lpr mice. Blood 97:3292\u20133299","journal-title":"Blood"},{"key":"840_CR19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2007.12.011","volume":"30","author":"S Ikehara","year":"2008","unstructured":"Ikehara S (2008) A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J Autoimmun 30:108\u2013113","journal-title":"J Autoimmun"},{"key":"840_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1634\/stemcells.22-2-125","volume":"22","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Inaba M, Sugiura K et al (2004) Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of graft-versus-host diseases (GvHD) by intra-bone marrow\u2013bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 22:125\u2013134","journal-title":"Stem Cells"},{"key":"840_CR21","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1073\/pnas.93.16.8558","volume":"93","author":"N Hosaka","year":"1996","unstructured":"Hosaka N, Nose M, Kyogoku M, Nagata N et al (1996) Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL\/+mice. Proc Natl Acad Sci USA 93:8558\u20138562","journal-title":"Proc Natl Acad Sci USA"},{"key":"840_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2249.2006.03310.x","volume":"147","author":"N Hosaka","year":"2007","unstructured":"Hosaka N, Ryu T, Miyake T et al (2007) Treatment of autoimmune diseases in MRL\/lpr mice by allogeneic bone marrow transplantation plus adult thymus transplantation. Clin Exp Immunol 147:555\u2013663","journal-title":"Clin Exp Immunol"},{"key":"840_CR23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2567.2008.02920.x","volume":"126","author":"T Miyake","year":"2009","unstructured":"Miyake T, Hosaka N, Cui W et al (2009) Adult thymus transplantation with allogeneic intra-bone marrow\u2013bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects. Immunology 126:552\u2013564","journal-title":"Immunology"},{"key":"840_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bmt.1705957","volume":"41","author":"T Ryu","year":"2008","unstructured":"Ryu T, Hosaka N, Miyake T et al (2008) Transplantation of newborn thymus plus hematopoietic stem cells can rescue supralethal irradiated mice. Bone Marrow Transplant 41:659\u2013666","journal-title":"Bone Marrow Transplant"},{"key":"840_CR25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/bmt.2008.396","volume":"43","author":"T Nishida","year":"2009","unstructured":"Nishida T, Hosaka N, Takaki T et al (2009) Allogeneic intra-BM\u2013BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection. Bone Marrow Transplant 43:829\u2013837","journal-title":"Bone Marrow Transplant"},{"key":"840_CR26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM199910143411603","volume":"341","author":"ML Markert","year":"1999","unstructured":"Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM (1999) Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med 341:1180\u20131189","journal-title":"N Engl J Med"},{"key":"840_CR27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/088922200309061","volume":"16","author":"ML Markert","year":"2000","unstructured":"Markert ML, Hicks CB, Bartlett JA, Harmon JL (2000) Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses 16:403\u2013413","journal-title":"AIDS Res Hum Retroviruses"},{"key":"840_CR28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0b013e31816a8f1f","volume":"85","author":"W Cui","year":"2008","unstructured":"Cui W, Hosaka N, Miyake T et al (2008) Analysis of tolerance induction using triple chimeric mice: MHC-disparate thymus, hemopoietic cells and microenvironment. Transplantation 85:1151\u20131158","journal-title":"Transplantation"},{"key":"840_CR29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","volume":"9","author":"M Edinger","year":"2003","unstructured":"Edinger M, Hoffmann P, Ermann J et al (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144\u20131150","journal-title":"Nat Med"},{"key":"840_CR30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.124.6.2845","volume":"124","author":"R Scollay","year":"1980","unstructured":"Scollay R, Jacobs S, Jerabek L, Butcher E, Weissman I (1980) T cell maturation: thymocyte and thymus migrant subpopulations defined with monoclonal antibodies to MHC region antigens. J Immunol 124:2845\u20132853","journal-title":"J Immunol"},{"key":"840_CR31","doi-asserted-by":"crossref","unstructured":"Lin YC, Chang LY, Huang CT, et al. Effector\/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. J Immunol 182:6095-6104","DOI":"10.4049\/jimmunol.0803829"},{"key":"840_CR32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","volume":"98","author":"T Sasada","year":"2003","unstructured":"Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A (2003) CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089\u20131099","journal-title":"Cancer"},{"key":"840_CR33","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","volume":"124","author":"X Xiang","year":"2009","unstructured":"Xiang X, Poliakov A, Liu C et al (2009) Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer 124:2621\u20132633","journal-title":"Int J Cancer"},{"key":"840_CR34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","volume":"135","author":"B Hoechst","year":"2008","unstructured":"Hoechst B, Ormandy LA, Ballmaier M et al (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135:234\u2013243","journal-title":"Gastroenterology"},{"key":"840_CR35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli F, Puig PE, Roux S et al (2005) Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 202:919\u2013929","journal-title":"J Exp Med"},{"key":"840_CR36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.cr.7310114","volume":"17","author":"L Zhang","year":"2007","unstructured":"Zhang L, Sun L, Zhao Y (2007) Thymic epithelial progenitor cells and thymus regeneration: an update. Cell Res 17:50\u201355","journal-title":"Cell Res"},{"key":"840_CR37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaut.2008.09.003","volume":"31","author":"T Takaki","year":"2008","unstructured":"Takaki T, Hosaka N, Miyake T et al (2008) Presence of donor-derived thymic epithelial cells in [B6\u2013>MRL\/lpr] mice after allogeneic intra-bone marrow\u2013bone marrow transplantation (IBM\u2013BMT). J Autoimmun 31:408\u2013415","journal-title":"J Autoimmun"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0840-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-010-0840-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0840-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T23:54:49Z","timestamp":1685490889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-010-0840-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s00262-010-0840-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,13]]}}}